Align Technology, Inc. (ALGN)
Align Technology (ALGN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Align Technology (ALGN) Q1 Earnings and Revenues Top Estimates
Align Technology (ALGN) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $1.98 per share. This compares to earnings of $2.14 per share a year ago.
What to Expect From These 3 MedTech Stocks This Earnings Season?
Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.
Analysts Estimate Align Technology (ALGN) to Report a Decline in Earnings: What to Look Out for
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ALGN Gears Up for Q1 Earnings: What Lies Ahead for the Stock?
Align Technology's first-quarter 2025 results are likely to reflect the strength in its Clear Aligner business.
ALGN or MMSI: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks?
ALGN Stock Gains From the Invisalign System With Mandibular Advancement
Align Technology's Invisalign System, featuring mandibular advancement with occlusal blocks, is now commercially available for Class II malocclusion in the growing number of patients.
Is This the Right Time to Hold ALGN Stock in Your Portfolio?
Align Technology continues to attract investors' confidence thanks to its share gains in the malocclusion market and strategic deals.
Align Technology: A Steady Leader in Dental Tech, but Is It Still a Buy?
Explore the exciting world of Align Technology (ALGN 1.11%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Why Is Align Technology (ALGN) Down 21.2% Since Last Earnings Report?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
Align Technology: Brace Yourself, This Stock Is Undervalued
Align Technology is undervalued with a P/FCF multiple of 15x and WACC of 11.55%, despite strong market share and margin improvements. ALGN's Invisalign dominates over 90% of the clear aligners market, supported by high switching costs and premium pricing power. Financials show solid adjusted EBIT margins at 21.8%, with adjusted EPS on an upward trend, despite pandemic-related sales growth stagnation.
ALGN Stock Gains on Addition of Upgrades to the iTero Lumina Solutions
Align Technology adds restorative capabilities to the iTero Lumina Solutions - the iTero Lumina intraoral scanner and the iTero Lumina Pro dental imaging system.
